Resistance to antibiotics and toxic compounds |
19 |
56 |
42 |
45 |
Mercury resistance operon |
1 |
0 |
0 |
0 |
Copper homeostasis |
6 |
25 |
18 |
18 |
Cobalt-zinc-cadmium resistance |
4 |
12 |
17 |
16 |
Resistance to fluoroquinolones |
2 |
5 |
2 |
5 |
Copper homeostasis: copper tolerance |
2 |
2 |
2 |
2 |
Beta-lactamase |
1 |
0 |
2 |
1 |
Mercuric reductase |
3 |
3 |
0 |
0 |
Multidrug Resistance Efflux Pumps |
0 |
7 |
0 |
0 |
Resistance to chromium compounds |
0 |
1 |
1 |
3 |
Invasion and intracellular resistance |
19 |
21 |
14 |
17 |
Mycobacterium virulence operon involved in protein synthesis (SSU ribosomal proteins) |
6 |
9 |
6 |
7 |
Mycobacterium virulence operon involved in DNA transcription |
3 |
6 |
2 |
4 |
Mycobacterium virulence operon possibly involved in quinolinate biosynthesis |
3 |
3 |
3 |
3 |
Listeria surface proteins: Internalin-like proteins |
4 |
0 |
0 |
0 |
Mycobacterium virulence operon involved in protein synthesis (LSU ribosomal proteins) |
3 |
3 |
3 |
3 |
Bacteriocins, ribosomally synthesized antibacterial peptides |
0 |
2 |
2 |
2 |
Tolerance to colicin E2 |
0 |
2 |
2 |
2 |
Membrane Transport |
14 |
77 |
86 |
83 |
Protein secretion system, Type II (Widespread colonization island) |
11 |
14 |
10 |
10 |
Protein secretion system, Type II (General Secretion Pathway) |
0 |
15 |
0 |
0 |
Protein secretion system, Type V (Two partner secretion pathway–TPS) |
0 |
4 |
0 |
0 |
Protein secretion system, Type I |
0 |
0 |
29 |
22 |
Protein secretion system, Type III |
0 |
0 |
0 |
0 |
Protein secretion system, Type VI |
0 |
0 |
0 |
0 |
Protein and nucleoprotein secretion system, Type IV (Type IV pilus) |
0 |
28 |
22 |
20 |
Protein and nucleoprotein secretion system, Type IV (Conjugative transfer) |
0 |
12 |
0 |
0 |
Protein secretion system, Type VII (Chaperone/Usher pathway, CU) |
0 |
0 |
13 |
12 |
Twin-arginine translocation system |
3 |
4 |
7 |
7 |
Protein secretion system, Type VIII (Extracellular nucleation/precipitation pathway, ENP) |
0 |
0 |
5 |
12 |